About

Publications While At HealthPartners

selected publications

Conference Poster

Phase 1/2 trial of the HPK1 inhibitor NDI-101150 as monotherapy and in combination with Pembrolizumab: clinical update [poster]. 

Journal of Clinical Oncology. 2024

Contact

full name

S. Dasen

Quick Info

 

Collaboration

Co-author network

Map of science